ASCEND BY NTHRYS
Research Abroad Products

Molecular Oncology Project Topics

Browse all focused areas across all project categories under this field.

Showing 49–60 of 220 project topics
Regulatory Pathway Intelligence and Approval Prediction Engine
A data-driven platform analyzing FDA kinase inhibitor precedents to predict approval likelihood and identify unmet regulatory requirements. Reduces development risk and optimizes clinical trial design, enabling clients to make go/no-go decisions with confidence.
Kinase & Signaling Oncology Drug Discovery Click to view more details →
Kinase Inhibitor Pharmacokinetics and Drug-Drug Interaction Simulator
A mechanistic PBPK modeling platform predicting CYP450 metabolism, transporter interactions, and multi-drug combination safety in silico. Reduces clinical pharmacology studies by 30% and accelerates regulatory approval, generating licensing revenue from enterprise pharma users.
Kinase & Signaling Oncology Drug Discovery Click to view more details →
AI-Powered DNA Methylation Pattern Recognition Platform
A SaaS platform that uses machine learning to detect and classify aberrant DNA methylation patterns in tumor samples with clinical-grade accuracy. Generates recurring revenue through per-sample analysis fees and institutional licensing while reducing diagnostic turnaround time by 60%.
Molecular Oncology Epigenetics Analytics Tools Click to view more details →
Real-Time Histone Modification Profiling Analytics Dashboard
Commercial software tool that integrates ChIP-seq and CUT-RUN data to visualize dynamic histone modifications across cancer cell populations in real time. Delivers competitive advantage to pharma companies by accelerating epigenetic biomarker discovery and enabling precision drug targeting strategies.
Molecular Oncology Epigenetics Analytics Tools Click to view more details →
Clinical-Grade Chromatin Accessibility Assessment Service
A managed service offering that processes ATAC-seq and DNase-seq data to quantify chromatin remodeling in oncology samples with pathologist-reviewed reports. Creates B2B revenue streams through tiered pricing for academic institutions, clinical labs, and pharmaceutical companies.
Molecular Oncology Epigenetics Analytics Tools Click to view more details →
Non-Coding RNA Expression Profiling Software Suite
Integrated platform that identifies and quantifies dysregulated lncRNAs, miRNAs, and circRNAs in tumor epigenomes with therapeutic relevance scoring. Monetizes through annual subscriptions, white-label licensing to diagnostic labs, and research collaborations with biotech firms.
Molecular Oncology Epigenetics Analytics Tools Click to view more details →
Epigenetic Drug Response Prediction Engine
Proprietary analytics tool that predicts patient response to epigenetic therapies using integrated DNA methylation, histone acetylation, and gene expression profiles. Drives premium pricing through companion diagnostic partnerships and licensing agreements with oncology pharmaceutical companies.
Molecular Oncology Epigenetics Analytics Tools Click to view more details →
Multi-Omics Epigenetic Integration Platform
Enterprise software that unifies methylome, chromatin, transcriptome, and proteomic data into actionable epigenetic signatures for cancer classification. Establishes competitive moats through institutional contracts with major cancer centers and enables precision oncology service revenue models.
Molecular Oncology Epigenetics Analytics Tools Click to view more details →
Tumor Heterogeneity Single-Cell Epigenetics Analyzer
Specialized SaaS platform processing scNMT-seq and scATAC-seq datasets to map epigenetic diversity within tumors and identify therapy-resistant subclones. Captures market value through high-volume sample processing fees and partnership opportunities with single-cell sequencing equipment manufacturers.
Molecular Oncology Epigenetics Analytics Tools Click to view more details →
CRISPR Epigenetic Screening Data Management System
Commercial platform that organizes, analyzes, and interprets results from large-scale epigenetic CRISPR screens targeting oncogenic pathways. Generates revenue through per-experiment fees, HTS core facility partnerships, and licensing to biotechnology companies conducting functional genomics research.
Molecular Oncology Epigenetics Analytics Tools Click to view more details →
Liquid Biopsy Epigenetic Biomarker Detection Pipeline
Clinical-ready software tool that identifies circulating tumor DNA methylation and histone-bound biomarkers from blood samples for early cancer detection. Creates high-margin recurring revenue through laboratory processing services, companion diagnostic partnerships, and institutional licensing agreements.
Molecular Oncology Epigenetics Analytics Tools Click to view more details →
Epigenetic Regulatory Network Mapping and Visualization Tool
Interactive analytics platform that constructs and visualizes gene regulatory networks driven by epigenetic modifications, enabling target prioritization for drug discovery. Monetizes through research subscriptions, pharma licensing fees, and integration partnerships with genomic analysis platforms.
Molecular Oncology Epigenetics Analytics Tools Click to view more details →